Efficacy And Safety Of Pirfenidone In Patients With Idiopathic Pulmonary Fibrosis: Comparison Of Mild/moderate Cases And Severe Cases

被引:0
|
作者
Kagami, R. [1 ]
Kawamura, T. [1 ]
Mochizuki, Y. [1 ]
Nakahara, Y. [1 ]
Sasaki, S. [1 ]
Morimoto, A. [1 ]
Terada, K. [1 ]
Tukamoto, H. [1 ]
Mizumori, Y. [1 ]
Yokoyama, T. [1 ]
Katsuda, R. [1 ]
Fukumitu, K. [1 ]
Shiraishi, S. [1 ]
Onishi, Y. [1 ]
Kato, T. [1 ]
Yokoi, Y. [1 ]
机构
[1] Himeji Med Ctr, Natl Hosp Org, Himeji, Hyogo, Japan
关键词
D O I
暂无
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
A1415
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Safety and efficacy of pirfenidone in severe idiopathic pulmonary fibrosis
    Ntolios, Paschalis
    Koulelidis, Andreas
    Zacharis, Georgios
    Tzouvelekis, Argyrios
    Boglou, Panagiotis
    Kaltsas, Konstantinos
    Bouros, Evangelos
    Karampitsakos, Theodoros
    Karailidou, Maria
    Steiropoulos, Paschalis
    Froudarakis, Manes
    Bouros, Demosthenes
    EUROPEAN RESPIRATORY JOURNAL, 2014, 44
  • [2] Efficacy and safety of pirfenidone for idiopathic pulmonary fibrosis
    Takeda, Yoshito
    Tsujino, Kazuyuki
    Kijima, Takashi
    Kumanogoh, Atsushi
    PATIENT PREFERENCE AND ADHERENCE, 2014, 8 : 361 - 370
  • [3] Efficacy and Safety of Pirfenidone in Advanced Idiopathic Pulmonary Fibrosis
    Yoon, Hee-Young
    Kim, Dong Soon
    Song, Jin Woo
    RESPIRATION, 2019, 97 (03) : 242 - 251
  • [4] EFFICACY OF PIRFENIDONE IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS
    Inagaki, Ai
    Tsutsumi, Takeo
    Kuriyama, Sachiko
    Nagaoka, Tetsutaro
    Sekiya, Mitsuaki
    Morio, Yoshiteru
    Takahashi, Kazuhisa
    RESPIROLOGY, 2013, 18 : 135 - 135
  • [5] Efficacy and safety of combined use of pirfenidone and nintedanib in patients with idiopathic pulmonary fibrosis
    Huh, Jin-Young
    Lee, Jae Ha
    Song, Jin Woo
    EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [6] Efficacy and safety of combination therapy with pirfenidone and nintedanib in patients with idiopathic pulmonary fibrosis
    Huh, Jin-Young
    Lee, Jae Ha
    Song, Jin Woo
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [7] Safety and efficacy of pirfenidone in idiopathic pulmonary fibrosis in clinical practice
    Okuda, Ryo
    Hagiwara, Eri
    Baba, Tomohisa
    Kitamura, Hideya
    Kato, Terufumi
    Ogura, Takashi
    RESPIRATORY MEDICINE, 2013, 107 (09) : 1431 - 1437
  • [8] CLINICAL EFFICACY OF PIRFENIDONE IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS
    Yamauchi, H.
    Bando, M.
    Sata, M.
    Nakasone, E.
    Mizushina, Y.
    Suzuki, E.
    Mato, N.
    Nakaya, T.
    Yamasawa, H.
    Sugiyama, Y.
    RESPIROLOGY, 2011, 16 : 318 - 319
  • [9] COST-EFFECTIVENESS OF PIRFENIDONE FOR THE TREATMENT OF PATIENTS WITH MILD TO MODERATE IDIOPATHIC PULMONARY FIBROSIS IN GREECE
    Vellopoulou, K.
    Kourlaba, G.
    Papageorgiou, L.
    Skroumpelos, A.
    Caporis, X.
    Maniadakis, N.
    VALUE IN HEALTH, 2018, 21 : S410 - S411
  • [10] Comparison of the efficacy of pirfenidone in patients with combined pulmonary fibrosis and emphysema and idiopathic pulmonary fibrosis without emphysema
    Gwon, Hye Ran
    Kim, Song Yee
    Park, Jong Sun
    Park, Moo Suk
    RESPIROLOGY, 2023, 28 : 358 - 358